Rongelap 40
HOSPITAL OF THE MEDICAL RESEARCH CENTER,
BROOKHAVEN NATIONAL LABORATORY
(NAME)
UPTON, NEW YORK 11973
08-45-42R
Aree Code 516 YAphank 4~6262
(UNIT NO.)
DISCHARGE SUMMARY
COURSE CONTIUED:
time of discharge on June 10th, he was symptom free and his thyroid of normal size.
cause of this episode is unclear.
The
AT the Metropolitan General
Dr. Brown Dobyns.
Hospital thyroid surgery was performed by
25 microcuries of 131 iodine were given orally the day before for
autoradiographic studies of removed thyroid tissues.
In surgery a firm area waa noted
at the junction of the right lobe and isthmus which contained several small nodules and
also several areas of nodularity were noted in isthmus.
The lower part of the isthms
and part of the right lobe were removed. The pathologist reported the lesions benign
with varying degrees of hyperthrophy, hyperplasia and fibrosis.
The patient withstood
the surgery well and his convalescence was uneventful.
He waa discharged on June 18th
to return to the Marshall Islands.
Copies of the Hospital Summary and Pathological
Reports from Cleveland incorporated with the BNL records.
PIAGNOSIS:
MEDICATION:
Thyroid lobular hyperplasia and hypertrophy
with slight fibrosis.
Continued treatment with L-thyroxin (3 MG-
day) is recommended since he is part of
the more heavily exposed Rongelap group, all of whom have been placed on such treatment
since 1965.
Kiker? <7 Ceme~ Se
Received:
Typed:
er
Robert A. Conard, M.D.
6*28-73
6-29-73
OM 720A
- 123 -